Comparison of Blood Cardioplegia and Custodiol
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01941459|
Recruitment Status : Completed
First Posted : September 13, 2013
Last Update Posted : September 13, 2013
Thru the last 20 years it has been a discussion witch solution that gives the best myocardial protection during cardiac arrest by heart operations.
- It has been a tendency that a blood based cardioplegia gives a better protection bye long ischemic times but it has not been possible too conclude in this matter.
- The investigators have two groups of cardioplegia, the blood based and, the crystalloid based cardioplegia.
- It has been done a lot of studies to see what kind of cardioplegia that gives the best myocardial protection. Different temperature, different amount and content, retrograde or antegrade or both, contentiously and further on have been tested without a clear conclusion.
- The investigators decided to make a study with a cohort of patients as homogenous as possible with a cross clamp time around 70 min.
- Adult patients' with a severe aortic stenoses without any other significant heart disease was included in our prospective randomised study.
- Patients with additional significant coronary artery disease (≥ 50% stenoses) were excluded from the study.
- The investigators used the well known biomarkers CK-MB and troponin-T too evaluate the myocardial damage.
|Condition or disease|
|Mitral Insufficiencies Myocardial Protection|
Objective: Myocardial protection during a cardiac arrest is mostly managed with cardioplegia. To day we normally used a blood or crystalloid based solutions. It has been published a lot of papers comparing the too groups with different results. To our knowledge no prospective, randomized study has compared modified St Thomas based Blood and Crystalloid cardioplegia on the acknowledged markers (CK-MB, troponin-T) of myocardial damage during aortic valve replacement on patients without additional significant coronary artery disease.
Methods: 100 patients with aorta stenoses undergoing aortic valve replacement without significant coronary artery stenoses or other significant concomitant heart valve disease were included in the study. They were given antegrade cold blood or cold crystalloid cardioplegia delivered through the coronary Ostia every 20 min throughout the period of aortic cross-clamp. CK-MB and troponin-T were compared between the two groups.
Published 2010 in the journal of thoracic and cardiovascular surgery.
|Study Type :||Observational|
|Actual Enrollment :||76 participants|
|Official Title:||Comparison of Blood Cardioplegia and Custodiol on Patients Operated for Significant Mitral Valve Innsufisiens. An Prospective, Randomized Two-center Study.|
|Study Start Date :||March 2007|
|Actual Primary Completion Date :||December 2009|
|Actual Study Completion Date :||January 2010|
2 Blood cardioplegia
- CK-MB ,troponin-T [ Time Frame: 72 hours ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01941459
|thoraxkirurgisk avd, UUS|
|Study Director:||Theis Tønnessen, prof.dr.med||Thoraxkirurgisk avd. UUS|
|Study Chair:||Bjørn Braathen, med.doc||Thoraxkir.avd. UUS|